US 9868725
Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease
granted A61KA61K31/045A61K31/13
Quick answer
US patent 9868725 (Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease) held by Takeda Pharmaceutical Company Limited expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/045, A61K31/13, A61K31/325, A61K31/4035